Chugai Pharmaceutical Co. Ltd.

08/08/2022 | Press release | Distributed by Public on 08/07/2022 20:33

Maruho Launched in Japan the Anti-IL-31 Receptor A Humanized Monoclonal Antibody Mitchga for the Treatment of Itching Associated with Atopic Dermatitis